Immunic Inc. (IMUX): Market Cap jumped to 239.28M


Immunic Inc. (NASDAQ:IMUX) changes shares on Wednesday trading session, with a change of 6.60% or $0.97 shares. The trading starts at $14.51 and closed at $14.70 throughout the day. The trading session low price was $14.24 and day high was $16.00 on Wednesday, June 24. After the session, the Healthcare sector daily volume shifted to 0.49 million while its average volume is 281.78K. In other hand, the IMUX market cap reached to $239.28M. While, its current target price is $15.67 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 15.39% and up 52.88% for month. Its quarterly performance was 115.54% above, while its half year performance is up 79.70%. IMUX yearly performance stood at positive 18.71% and rise 61.55% for year-to-date. Current recommendation for Immunic Inc. is 1.50.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. IMUX EPS (TTM) for 12-month is -3.88. EPS for this year is 88.40%, while for the next year its value is -3.22. Its EPS Q/Q reached -36.90%. It has an EPS of 49.80% up for past five years and for the next five years will be up 15.50%.

Let’s take a look on the analyst recommendations on IMUX for the current month and previous month. For the current month, 4 of 4 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 3 analysts participate in stock recommendation. Out of 3, 0 rated it sell, 3 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $44.00-$58.00. Average target price for IMUX was reached at $49.25.

Omega Fund Management (US) Inc., Artal Group S.A. and Renaissance Technologies, LLC are the top three holders in Immunic Inc. (IMUX) stock. On Mar 30, 2020, Omega Fund Management (US) Inc. has 1.37 million shares which valued 8.3 million. On Mar 30, 2020, Artal Group S.A. owned 0.63 million shares which valued at 3.81 million. On Mar 30, 2020, Renaissance Technologies, LLC has a total of 67931.0 shares which valued at 0.41 million. In the end, Renaissance Technologies, LLC have 0.45% shares outstanding of Immunic Inc. (IMUX) on Mar 30, 2020. The insider ownership moved to 2.30% and institutional holding shifted to 14.50%.

The company posted an EPS (TTM) of -3.88. According to the most recent quarter report on (Jun 2020), 4 analysts estimated an average EPS of -0.72, while -1.52 EPS posted a year ago period. Analyst Estimated EPS for IMUX published in the report was -0.86–0.57 during the same period. Comparing with last year, the average estimated EPS was -1.52 which is lower than -0.79 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for IMUX rise 72.82% for period of 200 days. SMA for 50 days was 50.30% which is showing green signal, while SMA-20 was 26.28%. The moving average value for Immunic Inc. (IMUX) is 8.86 and 11.23 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in IMUX stock. On Dec 04, Nash Duane, Director, sold 4,400 trading shares at the cost of $6.96, which valued at 30624.0.